Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
12 drugs in development
By Therapeutic Area
top 6
R&D Momentum
78/100
Pipeline Velocity
49/100
Trial Completion Rate
85/100
Pipeline Concentration
20/100
Pipeline Freshness
44/100
Strategic Signals
Activity
Last 14 days
Efficiency of Contemporary Off-line Adaptive Radiotherapy for Lung Cancer
The Effect of Perturbation Training on Reflex Modulation, Reactive Balance and Walking in Children With Spastic Cerebral Palsy.
Randomized Evaluation of fleCAinide Safety Versus STandard of Care in Patients With Coronary Artery Disease and Atrial Fibrillation
Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes: a Double Blind RCT
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)